Stanford Benjamin Rudnick

age:

41 years

appointments:

24 active

0 prior

primary industry:

Financial service activities, except insurance and pension funding

about Stanford

Since 2020, Mr Rudnick has been a director of 24 companies, the current directorship have a combined turnover of approximately £27.6m.

Combined Valuation

£4.1b

Combined Turnover

£27.6m

active directorships over time

company
turnover
valuation
start
end
status
role
alligent biopharm consulting (europe) limited£5.9m£1.2bDec 2024-OpenDirector
envision pharma midco limited-£784.3mDec 2024-OpenDirector
envision pharma finco limited-£718.2mDec 2024-OpenDirector
envision pharma bidco limited-£500.4mDec 2024-OpenDirector
evidence midco limited-£395.9mDec 2024-OpenDirector
evidence finco limited-£330.4mDec 2024-OpenDirector
engage scientific solutions limited£751.7k£34.3mDec 2024-OpenDirector
90ten ltd.£10.5m£26.4mDec 2024-OpenDirector
excel scientific solutions limited-£24.1mDec 2024-OpenDirector
elevate scientific solutions limited£392.7k£14.9mDec 2024-OpenDirector
evidence scientific solutions limited£711.9k£11.5mDec 2024-OpenDirector
curo consulting limited£447.1k£7.3mDec 2024-OpenDirector
touch creative design limited-£5.1mDec 2024-OpenDirector
envision pharma limited£7.3m£3.7mDec 2024-OpenDirector
okra technologies limited£630.6k£2.7mDec 2024-OpenDirector
90ten group limited-£2.2mDec 2024-OpenDirector
20senses limited£851k£1.4mDec 2024-OpenDirector
eloquent scientific solutions limited-£1.8Dec 2024-OpenDirector
envision pharma group limited--Dec 2024-OpenDirector
envision market access solutions limited--Dec 2024-OpenDirector
pennside partners uk limited--Dec 2024-OpenDirector
okra holdings limited--Dec 2024-OpenDirector
exeevo, inc.--Nov 2020-OpenDirector
envision pharma holdco limited--Dec 2024-OpenDirector